Vicore Pharma Holding AB (VCRE) Executive Compensation
Vicore Pharma Holding AB (VCRE) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: VCRE
CIK: 2124403
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: V7
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young AB
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJakob Grunditz
Audit LocationStockholm, Sweden
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-10-13 | — | SCHEDULE 13G Filing | 0001104659-26-115489 | View SEC Doc Filr Page |
| 6-K | 2026-09-30 | 2026-09-30 | FORM 6-K | 0001437749-26-031613 | View SEC Doc Filr Page |
| S-8 | 2026-08-21 | — | FORM S-8 | 0001104659-26-099739 | View SEC Doc Filr Page |
| 6-K | 2026-08-21 | 2026-08-21 | FORM 6-K | 0001104659-26-099719 | View SEC Doc Filr Page |
| 6-K | 2026-07-06 | 2026-07-06 | FORM 6-K | 0001104659-26-080617 | View SEC Doc Filr Page |
| SEC STAFF ACTION | 2026-06-30 | — | SEC STAFF ACTION Filing | 9999999997-26-001144 | View SEC Doc Filr Page |
| CERT | 2026-06-30 | — | CERT Filing | 0001354457-26-000627 | View SEC Doc Filr Page |
| 20FR12B/A | 2026-06-09 | — | 20FR12B/A | 0001104659-26-071924 | View SEC Doc Filr Page |
| 20FR12B | 2026-05-22 | — | 20FR12B | 0001104659-26-065450 | View SEC Doc Filr Page |
| DRS | 2026-04-17 | — | DRS Filing | 0001104659-26-044746 | View SEC Doc Filr Page |